
    
      There are two parts to this study:

        -  Phase 1: To determine a safe dose of the medication cyclophosphamide in combination with
           pomalidomide and dexamethasone.

        -  Phase 2: To see the difference in effectiveness of pomalidomide in combination with high
           dose dexamethasone with or without cyclophosphamide for the treatment of participants
           who have myeloma, which has relapsed to or become refractory (not responding) to prior
           treatment.
    
  